<DOC>
	<DOCNO>NCT00002793</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . Combining one drug give drug different way may kill tumor cell . PURPOSE : Randomized phase III trial compare effectiveness chemotherapy administer via implantable pump subcutaneous port unresectable liver metastases patient resect primary colorectal cancer .</brief_summary>
	<brief_title>Chemotherapy Via Implantable Pump Compared With Subcutaneous Port Unresectable Liver Metastases Patients With Resected Colorectal Cancer</brief_title>
	<detailed_description>OBJECTIVES : I . Compare efficacy 2 schedule fluorouracil/leucovorin give continuous intra-arterial infusion via implantable pump vs. subcutaneous port unresectable liver metastases patient colorectal cancer . II . Compare effect treatment response rate , quality life , rate technical complication patient . OUTLINE : Randomized study . The following acronym use : CF Leucovorin calcium , NSC-3590 5-FU Fluorouracil , NSC-19893 Arm I : Single-Agent Chemotherapy Drug Modulation . 5-FU ; CF . Weekly infusion via implantable pump . Arm II : Single-Agent Chemotherapy Drug Modulation . 5-FU ; CF . Weekly infusion via subcutaneous infusion port . Arm III : Single-Agent Chemotherapy Drug Modulation . 5-FU ; CF . Monthly infusion via implantable pump . Arm IV : Single-Agent Chemotherapy Drug Modulation . 5-FU ; CF . Monthly infusion via subcutaneous infusion port . PROJECTED ACCRUAL : A total 336 patient enter multicenter study .</detailed_description>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<mesh_term>Levoleucovorin</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Primary colorectal cancer unresectable liver metastases Less 75 % involvement liver Radical resection primary colon rectal tumor require No local recurrence extrahepatic metastases No portal vein thrombosis , ascites , cirrhosis PATIENT CHARACTERISTICS : Age : 18 76 Performance status : Karnofsky 70 % 100 % Hematopoietic : WBC great 3,000 Platelets great 100,000 Hepatic : Bilirubin great 4 mg/dL Alkaline phosphatase great 1,200 U/L Coagulation test normal Renal : Creatinine great 2.5 mg/dL Other : No prior malignancy PRIOR CONCURRENT THERAPY : See Disease Characteristics No prior intraarterial chemotherapy liver metastases No prior hepatic chemoembolization At least 3 month since fluorouracil</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>76 Years</maximum_age>
	<verification_date>May 2007</verification_date>
	<keyword>stage IV colon cancer</keyword>
	<keyword>stage IV rectal cancer</keyword>
	<keyword>recurrent colon cancer</keyword>
	<keyword>recurrent rectal cancer</keyword>
	<keyword>liver metastasis</keyword>
</DOC>